Novartis Czech Republic`s Operating Cost Growth reached 40.4 % in 2017. This is 28.6 % less than in the previous year.
Buy Operating Cost Growth data for Novartis Czech Republic.
$19.99Buy all data for Novartis Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | % | ... | ... | ... | ... | ... | 8.84 | -1.44 | 0.493 | -2.18 | -1.76 | |||||||
| Bayer Czech Republic | % | ... | ... | ... | -158 | -257 | 21.4 | 12.8 | 19.2 | |||||||||
| GlaxoSmithKline Czech Republic | % | ... | ... | ... | -34.4 | 52.8 | -2.39 | -1.60 | -21.5 | |||||||||
| Merck Czech Republic | % | ... | ... | 147 | -11.7 | -7.57 | 9.06 | 13.5 | ||||||||||
| Novartis Czech Republic | % | 8.43 | 6.24 | 17.6 | 39.1 | 8.21 | ||||||||||||
| Pfizer Czech Republic | % | ... | ... | -17.5 | -49.8 | 49.5 | -8.06 | -33.8 | ||||||||||
| Roche Czech Republic | % | ... | ... | ... | -3.47 | 4.38 | 2.78 | 12.6 | 157 | ... | ||||||||
| Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 2.80 | 10.9 | 2.48 | -7.42 | 27.8 | ||||||||
| Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -12.0 | 17.6 | 3.26 | ||
| Walmark | % | ... | ... | ... | -8.72 | 12.5 | -10.8 | 20.0 | -69.9 |
Helgi Library 
